40
Participants
Start Date
June 30, 2006
Study Completion Date
June 30, 2006
Moxifloxacin ophthalmic solution 0.5%
Gatifloxacin ophthalmic solution 0.3%
Ophthalmic Consultants of Boston, Boston
Collaborators (1)
Allergan
INDUSTRY
Ophthalmic Consultants of Boston
OTHER